Outcome Comparison of High-Risk Native American Patients Who Did or Did Not Receive Monoclonal Antibody Treatment for COVID-19
Overview
Affiliations
Lyeo J, Liberda E, Ahmed F, Charania N, Moriarity R, Tsuji L BMJ Public Health. 2025; 2(2):e001341.
PMID: 40018612 PMC: 11816692. DOI: 10.1136/bmjph-2024-001341.
Van Dyne E, Jentoft C, Boone T, Close R Am J Public Health. 2023; 113(10):1089-1092.
PMID: 37499203 PMC: 10484139. DOI: 10.2105/AJPH.2023.307364.
Hussein M, Wei W, Mastey V, Sanchez R, Wang D, Murdock D BMJ Open. 2022; 12(12):e064953.
PMID: 36535724 PMC: 9764096. DOI: 10.1136/bmjopen-2022-064953.
Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19.
Jalbert J, Hussein M, Mastey V, Sanchez R, Wang D, Murdock D Infect Dis Ther. 2022; 11(6):2125-2139.
PMID: 36181639 PMC: 9526200. DOI: 10.1007/s40121-022-00691-z.
Musshafen L, El-Sadek L, Lirette S, Summers R, Compretta C, Dobbs 3rd T JAMA Netw Open. 2022; 5(3):e224822.
PMID: 35353166 PMC: 8968465. DOI: 10.1001/jamanetworkopen.2022.4822.